Health-care mergers and transactions surged in August, led by activity in the pharmaceutical and medical device sectors.
The 1,125 deals announced or closed by the end of August were well ahead of the 900 deals for the same period in 2019.
There were 166 deals in August alone. That number was the highest since January, attorneys and health-care analysts reported.
Investment activity may be accelerating as the industry and the U.S. continues to respond to the economic disruption caused by the global Covid-19 pandemic, according to Larry Kocot, a principal at KPMG LLP and national leader of the firm’s ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.